GOODWILL AND OTHER INTANGIBLE ASSETS - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other intangible assets
Amortization of intangible assets	$ 9,700	$ 10,200	$ 9,900
Future estimated amortization, 2023	9,200
Future estimated amortization, 2024	8,400
Future estimated amortization, 2025	2,900
Future estimated amortization, 2026	1,400
Future estimated amortization, 2027	1,300
Impairment of other intangible assets	101	1,200	1,100
Payments to acquire intangible assets		300
Investigational Compound for Hematologic Diseases | Celgene
Other intangible assets
Impairment of other intangible assets	$ 98	610
Investigational Compound for Fibrotic Diseases | Celgene
Other intangible assets
Impairment of other intangible assets		230
Inrebic
Other intangible assets
Impairment of other intangible assets		315	575
Inrebic | Acquired marketed product rights
Other intangible assets
Finite-lived intangible assets, net		$ 385
Orva-cel
Other intangible assets
Impairment of other intangible assets			$ 470